semaglutide and pots A newly published case series reports that GLP-1 receptor agonists (like semaglutide Why Your POTS Got Worse

Topics include PSG development and bioequivalence study design, strategies for managing high intrasubject pharmacokinetic variability, FDA perspectives on drug product specifications and quality expectations, clinical considerations for oral peptide formulation approaches, and permeation enhancer selection for oral peptide delivery

Szarfman, A., Tonning, J

Remote ischemic Postconditioning-mediated neuroprotection against stroke by promoting ketone body-induced Ferroptosis inhibition

Sending signals to your brain that youre satisfied

Skin Repair Slows, Too Healthy skin relies on constant turnover old cells sloughing off, new ones rising to the surface

Patients who want a lower-dose titration option will need a different clinic